New VA study finds Paxlovid may cut the risk of long COVID
(By Pien Huang for NPR) It’s well-documented that Paxlovid — a 5-day course of antiviral pills from Pfizer — can
Read More(By Pien Huang for NPR) It’s well-documented that Paxlovid — a 5-day course of antiviral pills from Pfizer — can
Read MoreIt is open enrollment season for Medicare, Marketplace, and some employer groups. No matter what health insurance coverage you have,
Read More(Source – news.va.gov) VA, the Department of Housing and Urban Development (HUD), and the U.S. Interagency Council on Homelessness announced
Read More(By Zachary Levinson, Scott Hulver, and Tricia Neuman for Kaiser Family Foundation published November 3, 2022) About four in ten
Read More(By Farah Yousry, Side Effects Public Media for Kaiser Health News) When Susie Talevski sued the agency that managed her
Read More(By Rylee Wilson for Becker’s Hospital Review) Medicare Advantage marketing tactics can be aggressive, and sometimes deceptive, a Nov. 3
Read More(Source – cms.gov) COVID-19 has exacerbated the nation’s struggle with mental health and substance use disorders (collectively called “behavioral health
Read More(By Andrew Joseph for STAT) Federal health officials on Thursday updated their recommendations for using opioids to treat pain, removing
Read More(Source – news.va.gov) “Trust your gut” may sound like wishful thinking if you live with symptoms of irritable bowel syndrome
Read More(By Vanessa Romo for NPR) Temperatures are dropping and the risk of COVID-19 and influenza are up. And for the
Read More